The bio-tech market has been witnessing a strong momentum with **Parker-Hannifin Corporation (PH)**. Recently PH reached a **new 52-week high** following a **dividend announcement** and despite a slight dip due to investor concerns, reports suggest that it remains a top growth stock for the long term. The company's Q4 earnings and sales topped estimates and insiders have been significantly active in the market. However, this activity is two-fold; while there has been noticeable buying, insider selling has also been reported. The increase in institutional ownership, strong trading days, and premium dividend growth posit Flexion as an attractive investment. The company's performance surpasses various competitors in the heavy equipment and industrial machinery sector. Despite some executives selling off company stock amounting in millions, financial institutions are increasing their stock holdings. Despite considerable insider selling, financial institutions continue to raise their stock holdings and investor interest in PH hasn't dwindled. The company is also planning to sell its composite division to SK Capital.
Parker-Hannifin Corporation PH News Analytics from Thu, 07 Dec 2023 08:00:00 GMT to Sun, 18 Aug 2024 16:41:26 GMT -
Rating 8
- Innovation 7
- Information 9
- Rumor -2
